NEJM Interviews

Escolta'l a la teva aplicació

• Apple Podcasts
• Pocket Casts
• Castro
• Podcast Index
• RSS

Episodis

961 episodis

1. NEJM Interview: Irene Papanicolas on the role of profit in the U.S. health insurance sector and policy lessons from other countries. fa 3 dies 9:09
2. NEJM Interview: Anjali Deshmukh on legal challenges to fines issued by federal agencies. fa 1 setmana 14:29
3. NEJM Interview: Matthew Vogel on the emergence of clinical trial prediction markets. fa 2 setmanes 7:29
4. NEJM Interview: Lena Makaroun on opportunities for clinicians to address firearm-related risks with their older patients. fa 3 setmanes 13:49
5. NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity. fa 1 mes 5:35
6. NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds. fa 1 mes 8:50
7. NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends. fa 2 mesos 13:16
8. NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory. fa 2 mesos 9:23
9. NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services. fa 2 mesos 11:35
10. NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion. fa 2 mesos 11:53
11. NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research. fa 3 mesos 13:08
12. NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement. fa 3 mesos 8:55
13. NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness. fa 3 mesos 11:14
14. NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health. fa 3 mesos 14:12
15. NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines. fa 4 mesos 8:40
16. NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care. fa 4 mesos 8:05
17. NEJM Interview: Mark Unruh on projected increases in the need for long-term services and supports in the United States amid declines in nursing-home capacity. fa 4 mesos 5:40
18. NEJM Interview: Justin Barr on physician leadership in American society and politics over the past 250 years. fa 4 mesos 11:08
19. NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss. fa 5 mesos 13:06
20. NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States. fa 5 mesos 9:02
21. NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress. fa 5 mesos 12:17
22. NEJM Interview: Loren Adler on regulatory strategies for addressing factors that make consolidation in health care especially profitable. fa 5 mesos 10:14
23. NEJM Interview: Deirdre Tobias on the 2025–2030 Dietary Guidelines for Americans, including areas of confusion and contradiction. fa 5 mesos 14:27
24. NEJM Outbreaks Updates — Andes Hantavirus fa 6 mesos 27:53
25. NEJM Interview: Raja-Elie Abdulnour on the need for clinicians and AI systems to refrain from expressing undue confidence in their knowledge. fa 6 mesos 12:57
26. NEJM Interview: Jatin Vyas on the effect of corporatization of academic medical centers on medical education and trainee development. fa 6 mesos 8:53
27. NEJM Interview: Amanda Banks on concerns about a potential association between GLP-1 receptor agonists and restrictive eating disorders. fa 6 mesos 9:30
28. NEJM Interview: Sara Gerke on a Utah pilot program involving an AI system that autonomously renews certain prescriptions. fa 7 mesos 9:10
29. NEJM Interview: Amy Stimpfel on a new policy that would cap loans for graduate nursing and other students. fa 7 mesos 6:34
30. NEJM Interview: Danielle Jones on the development of tools to help family physicians address social determinants of health and advance health equity. fa 7 mesos 6:53
31. NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide. fa 7 mesos 12:30
32. NEJM Interview: Douglas Opel on the importance of clinician–parent communication amid changes to the childhood vaccine schedule. fa 8 mesos 9:26
33. NEJM Interview: Abbas Hassan on the gap between the services that residents and fellows provide and the revenue that hospitals can capture. fa 8 mesos 8:35
34. NEJM Interview: Ruqaiijah Yearby on recent trends in health care markets and their implications for health equity. fa 8 mesos 6:44
35. NEJM Interview: Bruce Chabner on recent FDA statements regarding potential uses for leucovorin. fa 9 mesos 6:38
36. NEJM Interview: Sonja Rasmussen on the 2025–2026 influenza season, including factors contributing to the intensity of influenza activity. fa 9 mesos 5:48
37. NEJM Interview: Carmel Shachar on the opportunities and risks presented by the Rural Health Transformation Program. fa 9 mesos 7:40
38. NEJM Interview: Leemore Dafny on the implications of corporatization of the U.S. health insurance industry. fa 9 mesos 11:27
39. NEJM Interview: Robert Kocher on strategies for improving blood-pressure control in the United States. fa 9 mesos 6:42
40. NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism. fa 10 mesos 14:20
41. NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency. fa 10 mesos 12:17
42. NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. fa 10 mesos 10:52
43. NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services. fa 1 any 9:57
44. NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend. fa 1 any 7:38
45. NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. fa 1 any 9:57
46. NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. fa 1 any 14:43
47. NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. fa 1 any 11:49
48. NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. fa 1 any 10:34
49. NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. fa 1 any 12:30
50. NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. fa 1 any 7:38